Federal Register of Legislation - Australian Government

Primary content

This instrument determines the brands of pharmaceutical items for which the price has increased on or after 1 July 2022 and the delegate has determined them to be considered "designated brands" under paragraph 99ADHC(1)(c) of the National Health Act 1953.
Administered by: Health and Aged Care
Registered 27 Sep 2022
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 94 of 2022

 

National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2022

I, Nikolai Tsyganov, as delegate for the Minister for Health and Aged Care, make the following determination.

Dated                                       27 September 2022

Nikolai Tsyganov

Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care

 

  

  

  


Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Definitions..................................................................................................................... 1

5............ Floor price of certain brands of pharmaceutical items.................................................... 1


1  Name

             (1)  This instrument is the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2022.

             (2)  This instrument may also be cited as PB 94 of 2022.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 October 2022.

1 October 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 99ADHC(2) of the National Health Act 1953.

4  Definitions

                   In this instrument:

Act means the National Health Act 1953.

brand has the same meaning as in Part VII of the Act.

pharmaceutical item has the same meaning as in Part VII of the Act.

5  Floor price of certain brands of pharmaceutical items

                   For the purposes of subsection 99ADHC(2) of the Act, paragraph 99ADHC(1)(c) of the Act applies to a brand of a pharmaceutical item mentioned in column 1 of an item in the following table.

Note:          Columns 2, 3 and 4 of the table are included for information only.

 

Floor price of certain brands of pharmaceutical items

Item

Column 1
Brand

Column 2
Drug

Column 3

Form

Column 4

Manner of administration

1

Dantrium

 

Dantrolene

Capsule containing dantrolene sodium hemiheptahydrate 25 mg

Oral

2

Cardizem

 

Diltiazem

Tablet containing diltiazem hydrochloride 60 mg

Oral

3

Diltiazem AN

 

Diltiazem

Tablet containing diltiazem hydrochloride 60 mg

Oral

4

Vasocardol

Diltiazem

Tablet containing diltiazem hydrochloride 60 mg

Oral

5

DBL Heparin Sodium

Heparin

Injection 5,000 units (as sodium) in 0.2 ml

Injection

6

Moduretic

 

Hydrochlorothiazide with amiloride

Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg

Oral

7

Penthrox

 

Methoxyflurane

Liquid for inhalation 999 mg per g, 3 ml (with inhaler)

Inhalation by mouth

8

Asmol CFC-Free with dose counter

 

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)

Inhalation by mouth

9

Ventolin CFC-Free with dose counter

 

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)

Inhalation by mouth

10

Zempreon CFC-Free with dose counter

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation)

Inhalation by mouth